Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

North America Inverter Market

ID: MRFR/EnP/53727-HCR
200 Pages
Chitranshi Jaiswal
Last Updated: February 06, 2026
North America Inverter Market Research Report By Type (Solar inverter, Vehicle inverter, Others), By Output Power Rating (Below 10 kW, 10-50 kW, 51-100 kW, Above 100 kW), By End User (Residential, Photovoltaic (PV) Plants, Automotive, Others), By Connection Type (Standalone, Grid-tied), By Output Voltage (100-300 V, 301-500 V, Above 500 V), By Sales Channel (Direct, Indirect) and By Regional (US, Canada)- Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Output Power Rating (USD Billion)
      1. 4.1.1 Below 10 kW
      2. 4.1.2 10-50 kW
      3. 4.1.3 51-100 kW
      4. 4.1.4 Above 100 kW
    2. 4.2 Pharmaceutical, BY End User (USD Billion)
      1. 4.2.1 Residential
      2. 4.2.2 Photovoltaic (PV) Plants
      3. 4.2.3 Automotive
      4. 4.2.4 Others
    3. 4.3 Pharmaceutical, BY Type (USD Billion)
      1. 4.3.1 Solar inverter
      2. 4.3.2 Vehicle inverter
      3. 4.3.3 Others
    4. 4.4 Pharmaceutical, BY Output Voltage (USD Billion)
      1. 4.4.1 100-300 V
      2. 4.4.2 301-500 V
      3. 4.4.3 Above 500 V
    5. 4.5 Pharmaceutical, BY Connection Type (USD Billion)
      1. 4.5.1 Standalone
      2. 4.5.2 Grid-tied
    6. 4.6 Pharmaceutical, BY Sales Channel (USD Billion)
      1. 4.6.1 Direct
      2. 4.6.2 Indirect
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 SMA Solar Technology AG (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Fronius International GmbH (AT)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 SolarEdge Technologies Inc (IL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Enphase Energy Inc (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 ABB Ltd (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Schneider Electric SE (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 TMEIC Corporation (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Huawei Technologies Co Ltd (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Victron Energy B.V. (NL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS BY OUTPUT POWER RATING
    3. 6.3 NORTH AMERICA MARKET ANALYSIS BY END USER
    4. 6.4 NORTH AMERICA MARKET ANALYSIS BY TYPE
    5. 6.5 NORTH AMERICA MARKET ANALYSIS BY OUTPUT VOLTAGE
    6. 6.6 NORTH AMERICA MARKET ANALYSIS BY CONNECTION TYPE
    7. 6.7 NORTH AMERICA MARKET ANALYSIS BY SALES CHANNEL
    8. 6.8 KEY BUYING CRITERIA OF PHARMACEUTICAL
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF PHARMACEUTICAL
    11. 6.11 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    13. 6.13 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    14. 6.14 PHARMACEUTICAL, BY OUTPUT POWER RATING, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY OUTPUT POWER RATING, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
    20. 6.20 PHARMACEUTICAL, BY OUTPUT VOLTAGE, 2024 (% SHARE)
    21. 6.21 PHARMACEUTICAL, BY OUTPUT VOLTAGE, 2024 TO 2035 (USD Billion)
    22. 6.22 PHARMACEUTICAL, BY CONNECTION TYPE, 2024 (% SHARE)
    23. 6.23 PHARMACEUTICAL, BY CONNECTION TYPE, 2024 TO 2035 (USD Billion)
    24. 6.24 PHARMACEUTICAL, BY SALES CHANNEL, 2024 (% SHARE)
    25. 6.25 PHARMACEUTICAL, BY SALES CHANNEL, 2024 TO 2035 (USD Billion)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY OUTPUT POWER RATING, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.2.3 BY TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY OUTPUT VOLTAGE, 2025-2035 (USD Billion)
      5. 7.2.5 BY CONNECTION TYPE, 2025-2035 (USD Billion)
      6. 7.2.6 BY SALES CHANNEL, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

North America Pharmaceutical Market Segmentation

Pharmaceutical By Output Power Rating (USD Billion, 2025-2035)

  • Below 10 kW
  • 10-50 kW
  • 51-100 kW
  • Above 100 kW

Pharmaceutical By End User (USD Billion, 2025-2035)

  • Residential
  • Photovoltaic (PV) Plants
  • Automotive
  • Others

Pharmaceutical By Type (USD Billion, 2025-2035)

  • Solar inverter
  • Vehicle inverter
  • Others

Pharmaceutical By Output Voltage (USD Billion, 2025-2035)

  • 100-300 V
  • 301-500 V
  • Above 500 V

Pharmaceutical By Connection Type (USD Billion, 2025-2035)

  • Standalone
  • Grid-tied

Pharmaceutical By Sales Channel (USD Billion, 2025-2035)

  • Direct
  • Indirect